MX9202976A - Una preparacion de etoposido. - Google Patents

Una preparacion de etoposido.

Info

Publication number
MX9202976A
MX9202976A MX9202976A MX9202976A MX9202976A MX 9202976 A MX9202976 A MX 9202976A MX 9202976 A MX9202976 A MX 9202976A MX 9202976 A MX9202976 A MX 9202976A MX 9202976 A MX9202976 A MX 9202976A
Authority
MX
Mexico
Prior art keywords
ethoposide
preparation
Prior art date
Application number
MX9202976A
Other languages
English (en)
Spanish (es)
Inventor
Takashi Terada
Hideyuki Ishimado
Masaru Suyuki
Minoru Nakada
Gen Iti Idzu
Original Assignee
Nippon Kayaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Kk filed Critical Nippon Kayaku Kk
Publication of MX9202976A publication Critical patent/MX9202976A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX9202976A 1985-02-19 1992-06-18 Una preparacion de etoposido. MX9202976A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60031203A JPS61189230A (ja) 1985-02-19 1985-02-19 エトポシド製剤

Publications (1)

Publication Number Publication Date
MX9202976A true MX9202976A (es) 1992-07-01

Family

ID=12324856

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9202976A MX9202976A (es) 1985-02-19 1992-06-18 Una preparacion de etoposido.

Country Status (10)

Country Link
US (1) US4734284A (https=)
EP (1) EP0193287B1 (https=)
JP (1) JPS61189230A (https=)
KR (1) KR920003332B1 (https=)
AU (1) AU583585B2 (https=)
DE (1) DE3671372D1 (https=)
DK (1) DK165902C (https=)
ES (1) ES8704727A1 (https=)
HU (1) HU196707B (https=)
MX (1) MX9202976A (https=)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8629639D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
US4940701A (en) * 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
US4927638A (en) * 1986-10-08 1990-05-22 Bristol-Myers Company Etoposide solutions
US4772589A (en) * 1986-10-29 1988-09-20 Bristol-Myers Etoposide solution in NMP
GB8629640D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
CA2017916C (en) * 1989-06-07 1999-02-02 Minoru Aoki Etoposide preparations
US5141961A (en) * 1991-06-27 1992-08-25 Richrdson-Vicks Inc. Process for solubilizing difficulty soluble pharmaceutical actives
US5447936A (en) * 1993-12-22 1995-09-05 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof
US5468754A (en) * 1994-04-19 1995-11-21 Bionumerik Pharmaceuticals, Inc. 11,7 substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereof
US5604233A (en) * 1994-04-28 1997-02-18 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of 7-ethyl camptothecin and methods for uses thereof
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
US7258869B1 (en) * 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
EP1152749B1 (en) * 1999-02-08 2006-04-12 ALZA Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
AU2001232344A1 (en) * 2000-02-21 2001-08-27 Fujisawa Pharmaceutical Co. Ltd. Liquid preparation with improved absorbability
ES2302926T5 (es) * 2002-04-25 2012-08-23 Banner Pharmacaps, Inc. Cápsula blanda masticable
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US20050220866A1 (en) * 2004-04-02 2005-10-06 Dr. Reddy's Laboratories Limited Novel capsule formulations of etoposide for oral use
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
MX2008014870A (es) 2006-05-30 2009-02-12 Intarcia Therapeutics Inc Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas.
EP2049081B1 (en) 2006-08-09 2012-11-14 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
HRP20130259T1 (hr) 2007-04-23 2013-04-30 Intarcia Therapeutics, Inc. Suspenzijske formulacije inzulinotropnih peptida i njihove uporabe
DK2240155T3 (da) 2008-02-13 2012-09-17 Intarcia Therapeutics Inc Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
SMT201700583T1 (it) 2009-09-28 2018-01-11 Intarcia Therapeutics Inc Instaurazione e/o terminazione rapida di erogazione di farmaci in modo sostanzialmente stazionario
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US10925639B2 (en) 2015-06-03 2021-02-23 Intarcia Therapeutics, Inc. Implant placement and removal systems
RU2760007C2 (ru) 2016-05-16 2021-11-22 Интарсия Терапьютикс, Инк. Полипептиды, селективные к рецепторам глюкагона, и способы их применения
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
CN110225762A (zh) 2017-01-03 2019-09-10 因塔西亚制药公司 包括glp-1受体激动剂的连续施用和药物的共同施用的方法
US20200338082A1 (en) * 2017-12-28 2020-10-29 Scott ACKLER Formulations, systems, and methods for therapeutic treatment
US20250295771A1 (en) 2022-05-11 2025-09-25 Celgene Corporation Methods and uses related to t cell therapy and production of same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH514578A (de) * 1968-02-27 1971-10-31 Sandoz Ag Verfahren zur Herstellung von Glucosiden
ZA728764B (en) * 1971-12-29 1973-08-29 Squibb & Sons Inc One piece gelatin capsules containing chloral hydrate
CA1184492A (en) * 1981-01-14 1985-03-26 Masataka Morishita Preparation having excellent absorption property
JPS5885813A (ja) * 1981-11-17 1983-05-23 Toyo Jozo Co Ltd 吸収性良好な製剤
JPS6032799A (ja) * 1983-07-29 1985-02-19 Microbial Chem Res Found 新規４′−デメチル−４−エピポドフィロトキシン誘導体
NZ211078A (en) * 1984-03-19 1987-08-31 Bristol Myers Co Oral dosage form of etoposide
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤
US4609644A (en) * 1984-06-15 1986-09-02 St. Jude Children's Research Hospital Epipodophyllotoxinquinone glucoside derivatives, method of production and use

Also Published As

Publication number Publication date
US4734284A (en) 1988-03-29
EP0193287A2 (en) 1986-09-03
JPS61189230A (ja) 1986-08-22
EP0193287B1 (en) 1990-05-23
DK165902B (da) 1993-02-08
EP0193287A3 (en) 1986-10-08
DK165902C (da) 1993-06-28
ES8704727A1 (es) 1987-04-16
AU583585B2 (en) 1989-05-04
KR920003332B1 (ko) 1992-04-27
AU5279386A (en) 1986-08-28
ES552067A0 (es) 1987-04-16
HUT43953A (en) 1988-01-28
DK75886D0 (da) 1986-02-18
DE3671372D1 (de) 1990-06-28
JPS6366810B2 (https=) 1988-12-22
DK75886A (da) 1986-08-20
KR860006263A (ko) 1986-09-09
HU196707B (en) 1989-01-30

Similar Documents

Publication Publication Date Title
MX9202976A (es) Una preparacion de etoposido.
FI870140L (fi) Orala vacciner.
ES542428A0 (es) Procedimiento de preparacion de una olefina polisulfurada.
DK60885D0 (da) Oralt praeparat
DE3673811D1 (de) Dentale desensibilisierende zubereitung.
DE3669437D1 (de) Entzuendungshemmende schmerzstillende anhaftende zubereitung.
DK178687A (da) Antikonvulsivt praeparat
KR880700906A (ko) 치합기구에서의 치형
IT8620777A0 (it) Capsula monometrica.
FI862638L (fi) Belastningsbegraensande anordning foer a/d-omformare av urladdningstyp.
ES546618A0 (es) Una muneca articulada
ES1000015Y (es) Una muneca
AR240319A1 (es) Procedimiento de preparacion de n-sulfamil-3-(2-guanidino-tiazol-4-il-metiltio)-propionamidina.
ES553705A0 (es) Un procedimiento para la preparacion de una alcanoilanilida
IT8647634A0 (it) Procedimento di preparazione di una fenilurea sostituita
NO863588D0 (no) Sammensetbart leketoey.
FI874337A7 (fi) Makua korjaava valmiste.
FI852876L (fi) Anordning foer undervattensarbete.
DK1987D0 (da) Maltningsfremgangsmaade maltningsfremgangsmaade
FI871811A7 (fi) Oksialkyyliselluloosaa sisältävä geelivalmiste.
RO91934A2 (ro) Procedeu de obtinere a n-cloracetil-n-fenil-2,6-dicloranilinei
ES545419A0 (es) Una estructura de somier
ES549242A0 (es) Una turboperforadora
KR870001688U (ko) 이쑤시게 함
NO872843L (no) Desensitiverende dentalpreparat.